Connection

Craig Crosson to Retinal Degeneration

This is a "connection" page, showing publications Craig Crosson has written about Retinal Degeneration.
Connection Strength

2.336
  1. Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Exp Eye Res. 2021 10; 211:108762.
    View in: PubMed
    Score: 0.694
  2. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury. Invest Ophthalmol Vis Sci. 2016 08 01; 57(10):4476-84.
    View in: PubMed
    Score: 0.487
  3. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. Exp Eye Res. 2014 Oct; 127:124-31.
    View in: PubMed
    Score: 0.423
  4. Inhibition of HDAC2 protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2013 Jun 12; 54(6):4072-80.
    View in: PubMed
    Score: 0.392
  5. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3853-9.
    View in: PubMed
    Score: 0.293
  6. Retinal preconditioning and the induction of heat-shock protein 27. Invest Ophthalmol Vis Sci. 2003 Mar; 44(3):1299-304.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.